The rise of Viagra initially sparked a period of growth for pharma, but recent shifts present a complicated picture for investors. Lower-cost alternatives are reducing revenue, and ongoing legal battles add additional https://nicoleblhy306300.post-blogs.com/62029284/viagra-and-big-pharma-a-precarious-play